Name | Lulizumab |
---|
Description | Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |